このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Integral Diagnostics マネジメント
マネジメント 基準チェック /24
Integral Diagnostics'の CEO はIan Kadishで、 May2017年に任命され、 の在任期間は 7.08年です。 の年間総報酬はA$ 1.10Mで、 71.2%給与と28.8%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.24%を直接所有しており、その価値はA$ 1.33M 。経営陣と取締役会の平均在任期間はそれぞれ3.8年と1.9年です。
主要情報
Ian Kadish
最高経営責任者
AU$1.1m
報酬総額
| CEO給与比率 | 71.2% |
| CEO在任期間 | 7.1yrs |
| CEOの所有権 | 0.2% |
| 経営陣の平均在職期間 | 3.8yrs |
| 取締役会の平均在任期間 | 1.9yrs |
経営陣の近況
Recent updates
Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital
Feb 21
Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being
Nov 22Integral Diagnostics' (ASX:IDX) Shareholders Will Receive A Smaller Dividend Than Last Year
Feb 20These 4 Measures Indicate That Integral Diagnostics (ASX:IDX) Is Using Debt Extensively
Dec 14Should You Think About Buying Integral Diagnostics Limited (ASX:IDX) Now?
May 26Integral Diagnostics (ASX:IDX) Is Paying Out Less In Dividends Than Last Year
Feb 28Integral Diagnostics Limited (ASX:IDX) Shares Could Be 38% Below Their Intrinsic Value Estimate
Feb 25Shareholders Would Not Be Objecting To Integral Diagnostics Limited's (ASX:IDX) CEO Compensation And Here's Why
Oct 29Does Integral Diagnostics (ASX:IDX) Deserve A Spot On Your Watchlist?
Sep 13An Intrinsic Calculation For Integral Diagnostics Limited (ASX:IDX) Suggests It's 22% Undervalued
Jun 04Should You Be Adding Integral Diagnostics (ASX:IDX) To Your Watchlist Today?
May 14Is Integral Diagnostics Limited (ASX:IDX) A Smart Choice For Dividend Investors?
May 03We Think Integral Diagnostics (ASX:IDX) Can Stay On Top Of Its Debt
Apr 16Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?
Mar 27Is Integral Diagnostics Limited's (ASX:IDX) Stock's Recent Performance A Reflection Of Its Financial Health?
Mar 17The Trends At Integral Diagnostics (ASX:IDX) That You Should Know About
Mar 07Here's What We Like About Integral Diagnostics' (ASX:IDX) Upcoming Dividend
Feb 25Is Integral Diagnostics Limited (ASX:IDX) Popular Amongst Institutions?
Feb 23Have Insiders Been Selling Integral Diagnostics Limited (ASX:IDX) Shares?
Feb 13Integral Diagnostics Limited's (ASX:IDX) Intrinsic Value Is Potentially 46% Above Its Share Price
Feb 03
Here's What We Learned About The CEO Pay At Integral Diagnostics Limited (ASX:IDX)
Jan 24Should You Use Integral Diagnostics's (ASX:IDX) Statutory Earnings To Analyse It?
Jan 14Shareholders Of Integral Diagnostics (ASX:IDX) Must Be Happy With Their 201% Total Return
Jan 05Is Integral Diagnostics (ASX:IDX) A Risky Investment?
Dec 26At AU$4.30, Is It Time To Put Integral Diagnostics Limited (ASX:IDX) On Your Watch List?
Dec 17What To Know Before Buying Integral Diagnostics Limited (ASX:IDX) For Its Dividend
Dec 08Returns On Capital At Integral Diagnostics (ASX:IDX) Paint An Interesting Picture
Nov 29Is Integral Diagnostics Limited's (ASX:IDX) Shareholder Ownership Skewed Towards Insiders?
Nov 19Is Integral Diagnostics (ASX:IDX) A Risky Investment?
Sep 20Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?
Sep 11Could Integral Diagnostics Limited (ASX:IDX) Have The Makings Of Another Dividend Aristocrat?
Sep 03CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -AU$58m |
| Sep 30 2023 | n/a | n/a | -AU$16m |
| Jun 30 2023 | AU$1m | AU$782k | AU$25m |
| Mar 31 2023 | n/a | n/a | AU$23m |
| Dec 31 2022 | n/a | n/a | AU$21m |
| Sep 30 2022 | n/a | n/a | AU$18m |
| Jun 30 2022 | n/a | AU$781k | AU$15m |
| Mar 31 2022 | n/a | n/a | AU$18m |
| Dec 31 2021 | n/a | n/a | AU$22m |
| Sep 30 2021 | n/a | n/a | AU$26m |
| Jun 30 2021 | AU$2m | AU$736k | AU$31m |
| Mar 31 2021 | n/a | n/a | AU$32m |
| Dec 31 2020 | n/a | n/a | AU$32m |
| Sep 30 2020 | n/a | n/a | AU$28m |
| Jun 30 2020 | AU$1m | AU$635k | AU$23m |
| Mar 31 2020 | n/a | n/a | AU$22m |
| Dec 31 2019 | n/a | n/a | AU$21m |
| Sep 30 2019 | n/a | n/a | AU$21m |
| Jun 30 2019 | AU$876k | AU$549k | AU$21m |
| Mar 31 2019 | n/a | n/a | AU$19m |
| Dec 31 2018 | n/a | n/a | AU$17m |
| Sep 30 2018 | n/a | n/a | AU$16m |
| Jun 30 2018 | AU$711k | AU$489k | AU$15m |
| Mar 31 2018 | n/a | n/a | AU$15m |
| Dec 31 2017 | n/a | n/a | AU$15m |
| Sep 30 2017 | n/a | n/a | AU$15m |
| Jun 30 2017 | AU$50k | AU$44k | AU$15m |
報酬と市場: Ianの 総報酬 ($USD 730.99K ) は、 Australian市場 ($USD 777.03K ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Ianの報酬は増加しましたが、会社は利益を上げていません。
CEO（最高経営責任者
Ian Kadish (61 yo)
7.1yrs
在職期間
AU$1,097,723
報酬
Dr. Ian Kadish, MBBCh, MBA, has been the Chief Executive Officer, Managing Director and Director at Integral Diagnostics Limited since May 22, 2017. Dr. Kadish serves as Independent Non-Executive Director...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO, MD & Director | 7.1yrs | AU$1.10m | 0.24% A$ 1.4m | |
| Executive Director | 4.6yrs | AU$1.05m | 0.011% A$ 61.2k | |
| Chief Financial Officer | less than a year | データなし | データなし | |
| Chief Information Officer | 4.8yrs | データなし | データなし | |
| General Counsel & Company Secretary | less than a year | データなし | データなし | |
| Chief Medical Officer | 2.9yrs | データなし | データなし |
3.8yrs
平均在職期間
経験豊富な経営陣: IDXの経営陣は 経験豊富 であると考えられます ( 3.8年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO, MD & Director | no data | AU$1.10m | 0.24% A$ 1.4m | |
| Executive Director | 4.6yrs | AU$1.05m | 0.011% A$ 61.2k | |
| Independent Non-Executive Director | 6.7yrs | AU$137.50k | 0.013% A$ 75.2k | |
| Independent Non-Executive Director | 1.9yrs | AU$131.77k | 0.036% A$ 206.6k | |
| Independent Non-Executive Director | less than a year | データなし | 0.015% A$ 85.0k | |
| Independent Non-Executive Director | less than a year | データなし | 0.065% A$ 368.7k |
1.9yrs
平均在職期間
59yo
平均年齢
経験豊富なボード: IDXの 取締役会 は 経験豊富 ではない ( 1.9年の平均在任期間) ため、新しい取締役会が必要であると考えられます。